Skip to main content
. 2021 Feb 15;26(2):187–193. doi: 10.5863/1551-6776-26.2.187

Table 2.

Comparison of Clinical Outcomes of All Hospitalized Patients Receiving Extended or Standard Infusion of Cefepime, Meropenem, or Piperacillin-Tazobactam

Clinical Outcomes Extended Infusion (n = 258) Standard Infusion (n = 293) p value
Hospital length of stay, median (IQR), days 9.8 (5.7–21.3) 9.7 (5.7–24.2) 0.981
Readmission within 30 days, n (%) 57 (22.1) 81 (27.6) 0.133
All-cause mortality within 30 days, n (%) 3 (1.2) 11 (3.8) 0.054